Because of the enhanced expression of vasoactive mediators (e.g., VEGF), induced apoptosis of endothelial cells, and increased tumor vascular permeability, RT can increase the accumulation of nanodrugs in tumor tissues (Ojha et al., 2017). The gene discussed is VEGFA; the disease is neoplasm.